Attitudes about Pharmacogenomic Testing Vary by Healthcare Specialty
Pharmacogenomics · 2023
DOI: 10.2217/pgs-2023-0039 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pharmacogenomics, 2023. Verfasst von Charlene L Preys und 9 weiteren Autor:innen. Beteiligte Einrichtung: MGH Institute of Health Professions, Charlestown, MA 02129, USA. Hauptthemen laut MEDLINE: Pharmacogenomic Testing, Attitude. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHGRI NIH HHS, Medical/Economic Impact and Behavioral Responses to Integrating the Sanford Chips, Sanford Health.
Abstract (Originalsprache)
Aim
To understand how attitudes toward pharmacogenomic (PGx) testing among healthcare providers varies by specialty.
Methods
Providers reported comfort ordering PGx testing and its perceived utility on web-based surveys before and after genetics education. Primary quantitative analyses compared primary care providers (PCPs) to specialty providers at both timepoints.
Results
PCPs were more likely than specialty care providers to rate PGx testing as useful at both timepoints. Education increased comfort ordering PGx tests, with larger improvements among PCPs than specialty providers. Over 90% of cardiology and internal medicine providers rated PGx testing as useful at pre- and post-education.
Conclusion
PCPs overwhelmingly perceive PGx to be useful, and provider education is particularly effective for improving PCPs' confidence. Education for all specialties will be essential to ensure appropriate integration into routine practice.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- MGH Institute of Health Professions, Charlestown, MA 02129, USA.
- Department of Medicine, Brigham and Women's Hospital, Boston, MA 02115, USA.
- Ariadne Labs, Boston, MA 02215, USA.
- Sanford Imagenetics, Sanford Health, Sioux Falls, SD 57105, USA.
- Department of Internal Medicine, University of South Dakota School of Medicine, Vermilion, SD 57069, USA.
- Broad Institute of Harvard and MIT, Cambridge, MA 02142, USA.
ORCID-Profile: Charlene L Preys, Carrie L Blout Zawatsky, Amanda Massmann, Joel Van Heukelom, Robert C Green, Catherine Hajek, Madison R Hickingbotham, Emilie S Zoltick, April Schultz, Kurt D Christensen
Förderung
- NHGRI NIH HHS
- Medical/Economic Impact and Behavioral Responses to Integrating the Sanford Chips
- Sanford Health
- National Institute of Mental Health
- Genome Medical, Inc.
- Helix OpCo
- Limited Liability Company
Zitieren
APA
Preys, C. L., Blout Zawatsky, C. L., Massmann, A., Heukelom, J. V., Green, R. C., Hajek, C., Hickingbotham, M. R., Zoltick, E. S., Schultz, A., & Christensen, K. D. (2023). Attitudes about Pharmacogenomic Testing Vary by Healthcare Specialty. Pharmacogenomics. https://doi.org/10.2217/pgs-2023-0039
Vancouver
Preys CL, Blout Zawatsky CL, Massmann A, Heukelom JV, Green RC, Hajek C, et al. Attitudes about Pharmacogenomic Testing Vary by Healthcare Specialty. Pharmacogenomics. 2023. doi:10.2217/pgs-2023-0039
BibTeX
@article{Preys2023,
author = {Preys, Charlene L and Blout Zawatsky, Carrie L and Massmann, Amanda and Heukelom, Joel Van and Green, Robert C and Hajek, Catherine and Hickingbotham, Madison R and Zoltick, Emilie S and Schultz, April and Christensen, Kurt D},
title = {Attitudes about Pharmacogenomic Testing Vary by Healthcare Specialty},
journal = {Pharmacogenomics},
year = {2023},
doi = {10.2217/pgs-2023-0039}
}
EUVIMED